Kim, Edward J. et al
"Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma." Clinical Cancer Research
20.23
(2014):
5937-5945.
Web. 24 Jan. 2021.